239 related articles for article (PubMed ID: 29745440)
1. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
2. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
5. Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling.
Hai L; Liu P; Yu S; Yi L; Tao Z; Zhang C; Abeysekera IR; Li T; Tong L; Ma H; Liu B; Xie Y; Zhou X; Lin Y; Zhu M; Zhang K; Ren B; Ming H; Huang Y; Yang X
Cell Physiol Biochem; 2018; 51(6):2925-2937. PubMed ID: 30580328
[TBL] [Abstract][Full Text] [Related]
6. The Role of Shcbp1 in Signaling and Disease.
Zhang GY; Ma ZJ; Wang L; Sun RF; Jiang XY; Yang XJ; Long B; Ye HL; Zhang SZ; Yu ZY; Shi WG; Jiao ZY
Curr Cancer Drug Targets; 2019; 19(11):854-862. PubMed ID: 31250756
[TBL] [Abstract][Full Text] [Related]
7. Repression of the expression of PPP3CC by ZEB1 confers activation of NF-κB and contributes to invasion and growth in glioma cells.
Wang H; Zhao S; Chen B; Fu C; Dang Y; Fang P; Wang J; Wang N; Liu L
Jpn J Clin Oncol; 2018 Feb; 48(2):175-183. PubMed ID: 29294030
[TBL] [Abstract][Full Text] [Related]
8. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
9. Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
Chen YH; Hueng DY; Tsai WC
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373180
[TBL] [Abstract][Full Text] [Related]
10. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
11. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
12. PROX1 promotes human glioblastoma cell proliferation and invasion via activation of the nuclear factor-κB signaling pathway.
Xu X; Wan X; Wei X
Mol Med Rep; 2017 Feb; 15(2):963-968. PubMed ID: 28035380
[TBL] [Abstract][Full Text] [Related]
13. PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients.
Xuan C; Jin M; Wang L; Xue S; An Q; Sun Q; Wang L; Gao Y
Biomed Res Int; 2020; 2020():1767056. PubMed ID: 32351983
[TBL] [Abstract][Full Text] [Related]
14. Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells.
Tao HC; Wang HX; Dai M; Gu CY; Wang Q; Han ZG; Cai B
Asian Pac J Cancer Prev; 2013; 14(10):5645-50. PubMed ID: 24289556
[TBL] [Abstract][Full Text] [Related]
15. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
Front Immunol; 2021; 12():785463. PubMed ID: 34887871
[TBL] [Abstract][Full Text] [Related]
16. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
17. Netrin-1 promotes glioma growth by activating NF-κB via UNC5A.
Chen JY; He XX; Ma C; Wu XM; Wan XL; Xing ZK; Pei QQ; Dong XP; Liu DX; Xiong WC; Zhu XJ
Sci Rep; 2017 Jul; 7(1):5454. PubMed ID: 28710382
[TBL] [Abstract][Full Text] [Related]
18. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas.
Wang H; Chen Z; Wang S; Gao X; Qian M; Qiu W; Zhang Z; Zhang S; Qi Y; Sun X; Xue H; Guo X; Zhao R; Li G
Mol Oncol; 2020 Feb; 14(2):407-425. PubMed ID: 31856384
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.
Luo G; Luo W; Sun X; Lin J; Wang M; Zhang Y; Luo W; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):187-193. PubMed ID: 27909726
[TBL] [Abstract][Full Text] [Related]
20. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]